Literature DB >> 16671482

Gravitational valves: relevant differences with different technical solutions to counteract hydrostatic pressure.

M Kiefer1, U Meier, R Eymann.   

Abstract

Two different technical principles of gravitational valves (G-valves) have been presented: counterbalancer and switcher G-valves. The objective of our prospective study was to look for clinically relevant differences between both. A total of 54 patients with normal-pressure hydrocephalus (NPH) were treated; 30 patients received an Aesculap-Miethke GA-Valve (GAV; counterbalancer), and in 24 patients an Aesculap-Miethke Dualswitch-Valve (DSV; switcher) was implanted. The opening pressure of the posture-independent valve was 5 cm H2O in both devices. The outcome was clearly better with the usage of the GAV than with the DSV. The frequency and severity of complications was pronounced in the DSV group. We recommend the Aesculap-Miethke-GAV valve with a low opening pressure in a posture-independent valve for patients with NPH.

Entities:  

Mesh:

Year:  2006        PMID: 16671482     DOI: 10.1007/3-211-30714-1_71

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  3 in total

Review 1.  Is there an ideal shunt? A panoramic view of 110 years in CSF diversions and shunt systems used for the treatment of hydrocephalus: from historical events to current trends.

Authors:  Nigel Peter Symss; Shizuo Oi
Journal:  Childs Nerv Syst       Date:  2014-12-30       Impact factor: 1.475

Review 2.  Shunting for normal pressure hydrocephalus (NPH).

Authors:  T Esmonde; S Cooke
Journal:  Cochrane Database Syst Rev       Date:  2002

3.  Safety and efficacy of gravitational shunt valves in patients with idiopathic normal pressure hydrocephalus: a pragmatic, randomised, open label, multicentre trial (SVASONA).

Authors:  Johannes Lemcke; Ullrich Meier; Cornelia Müller; Michael J Fritsch; Uwe Kehler; Niels Langer; Michael Kiefer; Regina Eymann; Martin U Schuhmann; Andreas Speil; Friedrich Weber; Victor Remenez; Veit Rohde; Hans-Christoph Ludwig; Dirk Stengel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-01       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.